Narrowly Defined Drug Patient Assistance Programs Spark OIG Advisory
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Office of Inspector General will give greater scrutiny to patient assistance programs that help enrollees in Medicare Part D plans purchase drugs if they only help patients with narrowly defined diseases or limit the range of drugs they will help cover, OIG says in updated guidance.